Specifically, high expression of stem cell marker CD44 corresponded to poor prognosis in kidney cancers (KIRC, KIRP) in TCGA data and, accordingly, high CD44 and b-catenin immunostaining correlated with advanced stage, although no significant correlation with survival could be observed in a specific focused study (117). This evidence concerns the gene CD44 and kidney cancer.